Author: Mary Inman, Esq. | November 12, 2026
Here’s a number that should get the attention of our audience: $166 million. That’s how much the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG) says one hospital may have been overpaid from the COVID Provider Relief Fund.
Part of the reason is that somewhere in the process, $755 million in quarterly revenue apparently became $157,000. Let me explain.
Last week, HHS-OIG released a report on the COVID-era Provider Relief Fund program, which was designed to keep healthcare providers afloat as lockdowns caused non-emergency healthcare utilization to plummet. The last phase of the program paid out about $19.3 billion to roughly 64,000 providers.
Each payment to a provider under the program was calculated as the greater of 2 percent of the provider’s patient care revenue or 88 percent of its reported COVID losses. The figures those calculations were based on were generally self-reported.
For the audit, OIG pulled a random sample of 150 providers. Every one of them was eligible under the Provider Relief Fund Program. But 65, or over 43 percent of the sampled providers, received payments that were miscalculated, and 39 (or 26 percent of the sampled providers) were potentially overpaid – by a whopping $655 million.
Health Resources and Services Administration (HRSA), the agency that administered the program, received more than 100,000 applications for provider relief funds. For about 95 percent of them, no humans reviewed the supporting documents. Providers didn’t have to document what share of their revenue came from patient care, and sometimes it would be impossible to do so retroactively. When the contractor couldn’t tell whether an item was patient care, HRSA assumed it was.
In its audit, OIG found that providers sometimes counted capitation and certain pharmacy revenues as patient care. Expense figures reported by providers also sometimes included advertising, gifts, travel, and alcohol. In one instance, a corporation documented its numbers via an individual’s tax returns. In another, a medical group claimed revenue from three subsidiaries without listing them, so earlier relief payments to those subsidiaries never got deducted.
All in all, OIG’s review pointed to a host of different problems, including the possibility of fraud and a meaningful error rate in the money that was paid out.
If these errors were knowing or intentional, they could constitute False Claims Act (FCA) violations. The FCA is a law that allows private individuals, whistleblowers, to sue in the name of the government and share in any recovery.
The law applies to any area where the government does business, but these days, the majority of cases and money recovered come from healthcare.
Knowingly reporting false data to HRSA to get a larger check from provider relief funds would be an example of fraud. This would apply if a provider overstated past patient care revenues, miscategorized other revenues as patient care revenues, or exaggerated the extent of COVID-related losses. Many factual fraud schemes would fall into these scenarios.
To date, provider relief funds have not been a major area of False Claims Act settlements. But with numbers and error rates like these, that’s likely changing soon.
This article was originally published on RACmonitor.